Complex Cases in the Management and Treatment of Patients with T2D and High CVD Risk
The management of patients with type 2 diabetes patients have evolved in last year, partly as a result of favorable EMPA-REG, CANVAS, and DECLARE TIMI-58 clinical trials.
Date: Thursday, June 25, 2020
Time: 12:00 pm – 1:00 pm ET
Join leading experts Christopher Cannon, MD, Cardiovascular Division at Brigham and Women’s Hospital and Professor of Medicine at Harvard Medical School, and Nathaniel G. Clark, MD, MS, RD at Beth Israel Deaconess Hospital – Plymouth, Endocrinology, June 25th 12:00 PM – 1:00 PM ET as they review complex cases and provide key clinical highlights from the ADA Virtual Scientific Sessions.